Loading...
Loading...
ACON| Name | Value |
|---|---|
| Revenues | 17.1K |
| Cost of Revenue | 19.3K |
| Gross Profit | -2.2K |
| Operating Expense | 1,404.0K |
| Operating I/L | -1,406.2K |
| Other Income/Expense | -58.4K |
| Interest Income | 47.1K |
| Pretax | -1,464.6K |
| Income Tax Expense | 35.9K |
| Net Income/Loss | -1,464.6K |
Aclarion, Inc. is a healthcare technology company in the United States that specializes in developing software applications for magnetic resonance spectroscopy (MRS). Their NOCISCAN-LS Post-Processor suite includes NOCICALC-LS, which processes disc MRS data to calculate levels of degenerative pain biomarkers, and NOCIGRAM-LS, a clinical decision support software. The company generates revenue by selling these software solutions to healthcare providers and institutions, enabling them to analyze and interpret MRS data for diagnostic and treatment purposes.
